Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
amlx
/
Amylyx Pharmaceuticals Inc
AMLX
Add to Watchlist
20.310
USD
-0.440
-2.12%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
2.26B
Market Cap
Loss
P/E TTM
Amylyx Pharmaceuticals Inc
20.310
-0.440
-2.12%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
13.43%
Perceptive Advisors LLC
7.45%
BlackRock Institutional Trust Company, N.A.
6.72%
TCG Crossover Management, LLC
5.62%
Commodore Capital LP
5.08%
Other
61.70%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
13.43%
Perceptive Advisors LLC
7.45%
BlackRock Institutional Trust Company, N.A.
6.72%
TCG Crossover Management, LLC
5.62%
Commodore Capital LP
5.08%
Other
61.70%
Shareholder Types
Shareholders
Proportion
Investment Advisor
42.93%
Hedge Fund
22.94%
Investment Advisor/Hedge Fund
21.26%
Individual Investor
7.91%
Private Equity
7.77%
Research Firm
4.92%
Venture Capital
3.76%
Bank and Trust
0.24%
Pension Fund
0.19%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
389
115.74M
104.12%
-8.56M
2025Q4
396
113.87M
99.16%
+1.57M
2025Q3
421
112.47M
102.70%
+27.99M
2025Q2
403
84.84M
117.02%
+7.84M
2025Q1
405
77.30M
91.06%
-3.38M
2024Q4
410
53.16M
117.27%
+2.39M
2024Q3
404
54.08M
130.01%
-4.93M
2024Q2
400
54.22M
128.23%
-6.16M
2024Q1
379
60.25M
120.54%
-21.45M
2023Q4
360
66.89M
115.11%
-1.53M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
14.93M
13.5%
+3.76M
+33.68%
Dec 31, 2025
Perceptive Advisors LLC
8.28M
7.5%
-667.48K
-7.46%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
7.48M
6.76%
+1.46M
+24.29%
Dec 31, 2025
TCG Crossover Management, LLC
6.24M
5.65%
--
--
Dec 31, 2025
Commodore Capital LP
5.65M
5.11%
--
--
Dec 31, 2025
Saturn V Capital Management LP
4.50M
4.07%
-108.39K
-2.35%
Dec 31, 2025
Janus Henderson Investors
4.47M
4.04%
+1.93M
+76.08%
Dec 31, 2025
Klee (Justin B)
3.58M
3.24%
+219.58K
+6.53%
Mar 05, 2026
Cohen (Joshua Barry)
3.58M
3.24%
+219.58K
+6.53%
Mar 05, 2026
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Pharmaceuticals ETF
1.5%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.38%
Invesco Dorsey Wright SmallCap Momentum ETF
1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
1.03%
Federated Hermes MDT Small Cap Core ETF
0.51%
iShares U.S. Pharmaceuticals ETF
0.42%
iShares Micro-Cap ETF
0.19%
ProShares Ultra Nasdaq Biotechnology
0.16%
Vanguard US Momentum Factor ETF
0.14%
Fidelity Fundamental Small-Mid Cap ETF
0.13%
View more
State Street SPDR S&P Pharmaceuticals ETF
Proportion
1.5%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion
1.38%
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion
1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion
1.03%
Federated Hermes MDT Small Cap Core ETF
Proportion
0.51%
iShares U.S. Pharmaceuticals ETF
Proportion
0.42%
iShares Micro-Cap ETF
Proportion
0.19%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.16%
Vanguard US Momentum Factor ETF
Proportion
0.14%
Fidelity Fundamental Small-Mid Cap ETF
Proportion
0.13%